Compare AYTU & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AYTU | ACCL |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 20.9M |
| IPO Year | N/A | 2025 |
| Metric | AYTU | ACCL |
|---|---|---|
| Price | $2.27 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | 88.9K | ★ 2.3M |
| Earning Date | 02-03-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.91 |
| EPS | N/A | ★ 0.08 |
| Revenue | ★ $62,640,000.00 | $4,888,824.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $47.32 | N/A |
| P/E Ratio | ★ N/A | $17.13 |
| Revenue Growth | 2.00 | ★ 11.91 |
| 52 Week Low | $0.95 | $1.23 |
| 52 Week High | $3.07 | $5.00 |
| Indicator | AYTU | ACCL |
|---|---|---|
| Relative Strength Index (RSI) | 39.79 | 29.39 |
| Support Level | $2.28 | $1.45 |
| Resistance Level | $2.50 | $1.69 |
| Average True Range (ATR) | 0.15 | 0.14 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 21.05 | 34.69 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.